{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:28:10Z","timestamp":1767137290767,"version":"build-2238731810"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>\n                    Hereditary hemochromatosis (HH) is a genetic disorder of iron metabolism that may lead to iron overload. Clinical penetrance is low, however those afflicted may develop cirrhosis, hepatocellular carcinoma, diabetes mellitus, and cardiomyopathy. Treatment of HH involves regular phlebotomy to reduce the systemic iron burden. In many countries\u2014including the United States\u2014numerous blood centers do not accept donated blood obtained from HH patients during therapeutic phlebotomy and there are inconsistent positions regarding this globally. This refusal of blood is borne out of a few concerns. First, there is a theoretical increase in the infectious risk of these blood products, particularly by siderophilic organisms such as\n                    <jats:italic toggle=\"yes\">Yersinia enterocolitica<\/jats:italic>\n                    . Second, given the increased incidence of hepatitis C infection from nonvoluntary donors in the 1970s, there is a concern that blood units from HH donors may harbor additional risk given the nonvoluntary nature of their presentation. In this review, we examine the existing biological and clinical data concerning infectious risk and summarize clinical experience from centers allowing HH donors, and demonstrate that blood from HH patients is safe and should be allowed into the donor pool. We conclude that there is no convincing evidence to exclude this population from serving as blood donors. (H\n                    <jats:sc>epatology<\/jats:sc>\n                    2018;67:1150\u20131157)\n                  <\/jats:p>","DOI":"10.1002\/hep.29521","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:42:40Z","timestamp":1505295760000},"page":"1150-1157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosis"],"prefix":"10.1097","volume":"67","author":[{"given":"Adam C.","family":"Winters","sequence":"first","affiliation":[{"name":"Department of Medicine,Icahn School of Medicine at Mount Sinai,New York,NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Department of Medicine,Icahn School of Medicine at Mount Sinai,New York,NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Arinsburg","sequence":"additional","affiliation":[{"name":"Department of Pathology,Icahn School of Medicine at Mount Sinai,New York,NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[{"name":"Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai,New York,NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Recanati\/Miller Transplantation Institute,Mount Sinai Medical Center,New York,NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"hep29521-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(15)01315-X","article-title":"Haemochromatosis","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"hep29521-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2015.09.006","article-title":"Ironing out ferroportin","volume":"22","year":"2015","journal-title":"Cell Metab"},{"key":"hep29521-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","year":"2009","journal-title":"Acta Haematol"},{"key":"hep29521-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"hep29521-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1001\/jama.285.17.2216","article-title":"Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"hep29521-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G\u2010\u2010> A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"hep29521-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMc080330","article-title":"Iron\u2010overload\u2010related disease in HFE hereditary hemochromatosis","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"hep29521-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep29521-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","year":"1985","journal-title":"N Engl J Med"},{"key":"hep29521-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s002770100371","article-title":"Clinically overt hereditary hemochromatosis in Denmark 1948\u20101985: epidemiology, factors of significance for long\u2010term survival, and causes of death in 179 patients","volume":"80","year":"2001","journal-title":"Ann Hematol"},{"key":"hep29521-bib-0011-20241017","first-page":"36","article-title":"Current approaches to the management of hemochromatosis","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"hep29521-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"American Association for the Study of Liver D. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"hep29521-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/vox.12038","article-title":"Worldwide policies on haemochromatosis and blood donation: a survey among blood services","volume":"105","year":"2013","journal-title":"Vox Sang"},{"key":"hep29521-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.286.12.1475","article-title":"Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis","volume":"286","year":"2001","journal-title":"JAMA"},{"key":"hep29521-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1537-2995.2005.04363.x","article-title":"Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion","volume":"45","year":"2005","journal-title":"Transfusion"},{"key":"hep29521-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.0042-9007.2004.00410.x","article-title":"Transfusion\u2010transmitted bacterial infection: risks, sources and interventions","volume":"86","year":"2004","journal-title":"Vox Sang"},{"key":"hep29521-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/MMBR.00012-07","article-title":"Siderophore\u2010based iron acquisition and pathogen control","volume":"71","year":"2007","journal-title":"Microbiol Mol Biol Rev"},{"key":"hep29521-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-010-8199-1","article-title":"The role of iron in the immune response to bacterial infection","volume":"50","year":"2011","journal-title":"Immunol Res"},{"key":"hep29521-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0163-4453(84)93955-0","article-title":"Functional defects in phagocytic cells from patients with iron overload","volume":"8","year":"1984","journal-title":"J Infect"},{"key":"hep29521-bib-0022-20241017","first-page":"1043","article-title":"The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease","volume":"4","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"hep29521-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1574-6976.1993.tb00026.x","article-title":"Iron uptake mechanisms of pathogenic bacteria","volume":"12","year":"1993","journal-title":"FEMS Microbiol Rev"},{"key":"hep29521-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.284.6315.542","article-title":"Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload","volume":"284","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"hep29521-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1172\/JCI109062","article-title":"The critical role of iron in host\u2010bacterial interactions","volume":"61","year":"1978","journal-title":"J Clin Invest"},{"key":"hep29521-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/iai.55.1.277-280.1987","article-title":"Expression of iron\u2010regulated proteins in Yersinia species and their relation to virulence","volume":"55","year":"1987","journal-title":"Infect Immun"},{"key":"hep29521-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.1991.00400080096018","article-title":"Hemochromatosis, iron and septicemia caused by Vibrio vulnificus","volume":"151","year":"1991","journal-title":"Arch Intern Med"},{"key":"hep29521-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.V72.4.1416.1416","article-title":"Nontransferrin\u2010bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy","volume":"72","year":"1988","journal-title":"Blood"},{"key":"hep29521-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/trf.12848","article-title":"Stored red blood cell transfusions: iron, inflammation, immunity, and infection","volume":"54","year":"2014","journal-title":"Transfusion"},{"key":"hep29521-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/trf.13890","article-title":"Properties of donated red blood cell components from patients with hereditary hemochromatosis","volume":"57","year":"2017","journal-title":"Transfusion"},{"key":"hep29521-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ajh.23534","article-title":"Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min","volume":"88","year":"2013","journal-title":"Am J Hematol"},{"key":"hep29521-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1537-2995.1999.39060651.x","article-title":"A survey of phlebotomy among persons with hemochromatosis","volume":"39","year":"1999","journal-title":"Transfusion"},{"key":"hep29521-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/jme.2002.001271","article-title":"Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients","volume":"31","year":"2005","journal-title":"J Med Ethics"},{"key":"hep29521-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-77-5-691","article-title":"Posttransfusion hepatitis after exclusion of commercial and hepatitis\u2010B antigen\u2010positive donors","volume":"77","year":"1972","journal-title":"Ann Intern Med"},{"key":"hep29521-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-92-4-539","article-title":"Post\u2010transfusion hepatitis: current perspectives","volume":"92","year":"1980","journal-title":"Ann Intern Med"},{"key":"hep29521-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vox.12130","article-title":"Measures of stored red blood cell quality","volume":"107","year":"2014","journal-title":"Vox Sang"},{"key":"hep29521-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1537-2995.2007.01547.x","article-title":"Red cell concentrates of hemochromatosis patients comply with the storage guidelines for transfusion purposes","volume":"48","year":"2008","journal-title":"Transfusion"},{"key":"hep29521-bib-0040-20241017","first-page":"575","article-title":"Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"hep29521-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1246-7820(02)00277-X","article-title":"Bacterial contamination and transfusion safety: experience in the United States","volume":"10","year":"2003","journal-title":"Transfus Clin Biol"},{"key":"hep29521-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1046\/j.1537-2995.2003.00570.x","article-title":"Hemochromatosis subjects as allogeneic blood donors: a prospective study","volume":"43","year":"2003","journal-title":"Transfusion"},{"key":"hep29521-bib-0043-20241017","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/00365520701368314","article-title":"No increased seroprevalence of anti\u2010Yersinia antibodies in patients with type 1 (C282Y\/C282Y) hemochromatosis","volume":"42","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"hep29521-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1572-0241.2008.02036.x","article-title":"Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE\u2010related genetic hemochromatosis","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep29521-bib-0045-20241017","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jama.289.11.1364","article-title":"Hemochromatosis patients are untapped source of blood as war, shortages loom","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"hep29521-bib-0047-20241017","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1537-2995.1999.39091018.x","article-title":"Use of blood therapeutically drawn from hemochromatosis patients. Council on Scientific Affairs, American Medical Association","volume":"39","year":"1999","journal-title":"Transfusion"},{"key":"hep29521-bib-0050-20241017","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21307\/immunohematology-2019-251","article-title":"Cost\u2010effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398\u2010bed hospital\u2010based donor center","volume":"25","year":"2009","journal-title":"Immunohematology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.29521","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201803000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:51:43Z","timestamp":1729194703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201803000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":43,"aliases":["10.1002\/hep.29589"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.29521","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"2017-05-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}